Skip to main content
. 2016 Apr 7;82(1):83–91. doi: 10.1111/bcp.12917

Figure 1.

Figure 1

Plasma concentration vs. time curves of the nebivolol enantiomers in patients in the control (n = 22), chronic kidney disease (CKD) (n = 11) and haemodialysis (n = 10) groups treated with a single oral dose of 10 mg racemic nebivolol. Values are expressed as the mean ± standard error of the mean